The cardiovascular and soft tissue repair patches market size has grown rapidly in recent years. It will grow from $4.85 billion in 2025 to $5.41 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increasing incidence of congenital heart defects, expansion of cardiovascular surgical procedures, adoption of synthetic repair patches, advancements in biomaterial science, growing availability of specialized cardiac surgery centers.
The cardiovascular and soft tissue repair patches market size is expected to see rapid growth in the next few years. It will grow to $8.09 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing demand for regenerative cardiovascular treatments, rising investments in tissue engineering research, expansion of advanced cardiac reconstruction procedures, growing focus on absorbable patch materials, increasing adoption of personalized repair solutions. Major trends in the forecast period include increasing adoption of biologic repair patches, rising use of tissue-engineered materials, growing focus on regenerative cardiac therapies, expansion of minimally invasive patch implantation, enhanced emphasis on biocompatibility and healing.
The increasing demand for patches related to cardiac disease is projected to drive the growth of the cardiovascular and soft tissue repair patches market. Cardiac disease encompasses a range of disorders associated with the heart and blood vessels. The rising need for patches addressing cardiac conditions is largely influenced by lifestyle factors, including smoking and alcohol consumption. For instance, in May 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency based in Georgia, reported that in 2022, heart disease led to 702,880 deaths, accounting for 1 in every 5 fatalities. This equates to one individual succumbing to cardiovascular disease every 33 seconds. Each year, about 805,000 people in the United States suffer a heart attack, of which 605,000 are experiencing their first heart attack, while 200,000 have had a previous heart attack. Thus, the increasing demand for patches related to cardiac disease is expected to drive the cardiovascular and soft tissue repair patches market in the coming years.
Major players in the cardiovascular and soft tissue repair patches market are developing advanced expandable, bio-integrative surgical patches to meet demand for long-term, biocompatible implants that accommodate patient growth and reduce re-interventions. These patches combine bio-absorbable and non-absorbable yarns within a knitted structure coated with cross-linked gelatin; the absorbable portion degrades while native tissue grows in, lowering foreign-body response and inflammation. In July 2023, Teijin Limited received regulatory approval in Japan for SYNFOLIUM®, a patch designed to prevent blood leakage, promote tissue regeneration, and expand with physiological growth, reducing risks of calcification, stiffening, and immune reactions.
In June 2024, Stryker, a US-based manufacturer of medical equipment, acquired Artelon for an undisclosed sum. This acquisition is intended to expand its product portfolio in joint preservation and soft tissue reconstruction. Artelon focuses on developing innovative biomaterials for soft tissue reinforcement and repair, especially in the areas of sports medicine and extremities procedures. Artelon is based in Georgia and specializes in medical equipment manufacturing.
Major companies operating in the cardiovascular and soft tissue repair patches market are B. Braun, Baxter International Inc., CorMatrix Cardiovascular Inc., CryoLife Inc., Edwards Lifesciences Corporation, LeMaitre Vascular Inc., Anteris Technologies Limited, Abbott Laboratories, Terumo Medical Corporation, Integra LifeSciences Corporation, W. L. Gore & Associates Inc., Medtronic Inc., LifeCell Corporation, ACell Inc., Tissue Regenix Group Plc, Aroa Biosurgery Ltd., LifeNet Health Inc., Cook Medical, Getinge AB, Glycar SA Pty Ltd., Biointegral Surgical Inc., Admedus Ltd., Johnson & Johnson, Stryker Corporation, Zimmer Biomet, Smith & Nephew plc, Organogenesis Inc.
North America was the largest region in the cardiovascular and soft tissue repair patches market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular and soft tissue repair patches market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular and soft tissue repair patches market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the cardiovascular and soft tissue repair patches market by increasing costs of imported biomaterials, polymers, processing equipment, and sterilization technologies. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported patch materials, while Asia-Pacific faces manufacturing cost pressures. These tariffs are increasing treatment costs and slowing adoption in some settings. However, they are also encouraging domestic biomaterial production, regional manufacturing expansion, and innovation in cost-effective tissue repair solutions.
The cardiovascular and soft tissue repair patches market research report is one of a series of new reports that provides cardiovascular and soft tissue repair patches market statistics, including cardiovascular and soft tissue repair patches industry global market size, regional shares, competitors with a cardiovascular and soft tissue repair patches market share, detailed cardiovascular and soft tissue repair patches market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular and soft tissue repair patches industry. This cardiovascular and soft tissue repair patches market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cardiovascular and soft tissue repair patches are artificial tissues created in the laboratory, composed of tissues grown in vitro and polymers. These patches serve the purpose of restoring damaged body tissues, providing mechanical regeneration support for injured myocardium layers, and reinstating the functional characteristics of damaged tissues for the treatment of cardiovascular diseases.
The primary raw materials used in the production of cardiovascular and soft tissue repair patches include ePTFE (expanded Polytetrafluoroethylene), biomaterial and tissue-engineered material, and other relevant raw materials. ePTFE, a material commonly used in medical devices like catheters and cardiac sutures, is composed of tetrafluoroethylene polymer units and is known for its biocompatible properties. The resulting products include synthetic patches and biological patches, with applications ranging from cardiac repair to various heart-related conditions such as atrial septal defect, ventricular septal defect, and vascular repair. The end users of cardiovascular and soft tissue repair patches encompass hospitals, ambulatory surgical centers, and specialty clinics.
The cardiovascular and soft tissue repair patches market consists of sales of xenogeneic patch and allogeneic patch. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The cardiovascular and soft tissue repair patches market size is expected to see rapid growth in the next few years. It will grow to $8.09 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing demand for regenerative cardiovascular treatments, rising investments in tissue engineering research, expansion of advanced cardiac reconstruction procedures, growing focus on absorbable patch materials, increasing adoption of personalized repair solutions. Major trends in the forecast period include increasing adoption of biologic repair patches, rising use of tissue-engineered materials, growing focus on regenerative cardiac therapies, expansion of minimally invasive patch implantation, enhanced emphasis on biocompatibility and healing.
The increasing demand for patches related to cardiac disease is projected to drive the growth of the cardiovascular and soft tissue repair patches market. Cardiac disease encompasses a range of disorders associated with the heart and blood vessels. The rising need for patches addressing cardiac conditions is largely influenced by lifestyle factors, including smoking and alcohol consumption. For instance, in May 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency based in Georgia, reported that in 2022, heart disease led to 702,880 deaths, accounting for 1 in every 5 fatalities. This equates to one individual succumbing to cardiovascular disease every 33 seconds. Each year, about 805,000 people in the United States suffer a heart attack, of which 605,000 are experiencing their first heart attack, while 200,000 have had a previous heart attack. Thus, the increasing demand for patches related to cardiac disease is expected to drive the cardiovascular and soft tissue repair patches market in the coming years.
Major players in the cardiovascular and soft tissue repair patches market are developing advanced expandable, bio-integrative surgical patches to meet demand for long-term, biocompatible implants that accommodate patient growth and reduce re-interventions. These patches combine bio-absorbable and non-absorbable yarns within a knitted structure coated with cross-linked gelatin; the absorbable portion degrades while native tissue grows in, lowering foreign-body response and inflammation. In July 2023, Teijin Limited received regulatory approval in Japan for SYNFOLIUM®, a patch designed to prevent blood leakage, promote tissue regeneration, and expand with physiological growth, reducing risks of calcification, stiffening, and immune reactions.
In June 2024, Stryker, a US-based manufacturer of medical equipment, acquired Artelon for an undisclosed sum. This acquisition is intended to expand its product portfolio in joint preservation and soft tissue reconstruction. Artelon focuses on developing innovative biomaterials for soft tissue reinforcement and repair, especially in the areas of sports medicine and extremities procedures. Artelon is based in Georgia and specializes in medical equipment manufacturing.
Major companies operating in the cardiovascular and soft tissue repair patches market are B. Braun, Baxter International Inc., CorMatrix Cardiovascular Inc., CryoLife Inc., Edwards Lifesciences Corporation, LeMaitre Vascular Inc., Anteris Technologies Limited, Abbott Laboratories, Terumo Medical Corporation, Integra LifeSciences Corporation, W. L. Gore & Associates Inc., Medtronic Inc., LifeCell Corporation, ACell Inc., Tissue Regenix Group Plc, Aroa Biosurgery Ltd., LifeNet Health Inc., Cook Medical, Getinge AB, Glycar SA Pty Ltd., Biointegral Surgical Inc., Admedus Ltd., Johnson & Johnson, Stryker Corporation, Zimmer Biomet, Smith & Nephew plc, Organogenesis Inc.
North America was the largest region in the cardiovascular and soft tissue repair patches market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular and soft tissue repair patches market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular and soft tissue repair patches market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the cardiovascular and soft tissue repair patches market by increasing costs of imported biomaterials, polymers, processing equipment, and sterilization technologies. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported patch materials, while Asia-Pacific faces manufacturing cost pressures. These tariffs are increasing treatment costs and slowing adoption in some settings. However, they are also encouraging domestic biomaterial production, regional manufacturing expansion, and innovation in cost-effective tissue repair solutions.
The cardiovascular and soft tissue repair patches market research report is one of a series of new reports that provides cardiovascular and soft tissue repair patches market statistics, including cardiovascular and soft tissue repair patches industry global market size, regional shares, competitors with a cardiovascular and soft tissue repair patches market share, detailed cardiovascular and soft tissue repair patches market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular and soft tissue repair patches industry. This cardiovascular and soft tissue repair patches market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cardiovascular and soft tissue repair patches are artificial tissues created in the laboratory, composed of tissues grown in vitro and polymers. These patches serve the purpose of restoring damaged body tissues, providing mechanical regeneration support for injured myocardium layers, and reinstating the functional characteristics of damaged tissues for the treatment of cardiovascular diseases.
The primary raw materials used in the production of cardiovascular and soft tissue repair patches include ePTFE (expanded Polytetrafluoroethylene), biomaterial and tissue-engineered material, and other relevant raw materials. ePTFE, a material commonly used in medical devices like catheters and cardiac sutures, is composed of tetrafluoroethylene polymer units and is known for its biocompatible properties. The resulting products include synthetic patches and biological patches, with applications ranging from cardiac repair to various heart-related conditions such as atrial septal defect, ventricular septal defect, and vascular repair. The end users of cardiovascular and soft tissue repair patches encompass hospitals, ambulatory surgical centers, and specialty clinics.
The cardiovascular and soft tissue repair patches market consists of sales of xenogeneic patch and allogeneic patch. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Cardiovascular and Soft Tissue Repair Patches Market Characteristics
3. Cardiovascular and Soft Tissue Repair Patches Market Supply Chain Analysis
4. Global Cardiovascular and Soft Tissue Repair Patches Market Trends and Strategies
5. Cardiovascular and Soft Tissue Repair Patches Market Analysis of End Use Industries
7. Global Cardiovascular and Soft Tissue Repair Patches Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Cardiovascular and Soft Tissue Repair Patches Total Addressable Market (TAM) Analysis for the Market
9. Cardiovascular and Soft Tissue Repair Patches Market Segmentation
10. Cardiovascular and Soft Tissue Repair Patches Market Regional and Country Analysis
11. Asia-Pacific Cardiovascular and Soft Tissue Repair Patches Market
12. China Cardiovascular and Soft Tissue Repair Patches Market
13. India Cardiovascular and Soft Tissue Repair Patches Market
14. Japan Cardiovascular and Soft Tissue Repair Patches Market
15. Australia Cardiovascular and Soft Tissue Repair Patches Market
16. Indonesia Cardiovascular and Soft Tissue Repair Patches Market
17. South Korea Cardiovascular and Soft Tissue Repair Patches Market
18. Taiwan Cardiovascular and Soft Tissue Repair Patches Market
19. South East Asia Cardiovascular and Soft Tissue Repair Patches Market
20. Western Europe Cardiovascular and Soft Tissue Repair Patches Market
21. UK Cardiovascular and Soft Tissue Repair Patches Market
22. Germany Cardiovascular and Soft Tissue Repair Patches Market
23. France Cardiovascular and Soft Tissue Repair Patches Market
24. Italy Cardiovascular and Soft Tissue Repair Patches Market
25. Spain Cardiovascular and Soft Tissue Repair Patches Market
26. Eastern Europe Cardiovascular and Soft Tissue Repair Patches Market
27. Russia Cardiovascular and Soft Tissue Repair Patches Market
28. North America Cardiovascular and Soft Tissue Repair Patches Market
29. USA Cardiovascular and Soft Tissue Repair Patches Market
30. Canada Cardiovascular and Soft Tissue Repair Patches Market
31. South America Cardiovascular and Soft Tissue Repair Patches Market
32. Brazil Cardiovascular and Soft Tissue Repair Patches Market
33. Middle East Cardiovascular and Soft Tissue Repair Patches Market
34. Africa Cardiovascular and Soft Tissue Repair Patches Market
36. Cardiovascular and Soft Tissue Repair Patches Market Competitive Landscape and Company Profiles
37. Cardiovascular and Soft Tissue Repair Patches Market Other Major and Innovative Companies
40. Cardiovascular and Soft Tissue Repair Patches Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Cardiovascular And Soft Tissue Repair Patches Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses cardiovascular and soft tissue repair patches market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cardiovascular and soft tissue repair patches? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular and soft tissue repair patches market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Raw Materials: ePTFE; Biomaterial and Tissue-Engineered Material; Other Raw Materials2) By Product: Synthetic Patch; Biologic Patch
3) By Application: Cardiac Repair; Atrial Septal Defect; Ventricular Septal Defect; Tetralogy Of Fallot; Right Ventricular Outflow Tract Reconstruction; Vascular Repair And Reconstruction; Transposition Of The Great Vessels
4) By End User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics
Subsegments:
1) By ePTFE (Expanded Polytetrafluoroethylene): Non-Absorbable ePTFE Patches; Absorbable ePTFE Patches2) By Biomaterial and Tissue-Engineered Material: Collagen-Based Patches; Synthetic Polymer-Based Patches; Decellularized Tissue Patches
3) By Other Raw Materials: Silicones; Hydrogel-Based Materials; Natural Materials
Companies Mentioned: B. Braun; Baxter International Inc.; CorMatrix Cardiovascular Inc.; CryoLife Inc.; Edwards Lifesciences Corporation; LeMaitre Vascular Inc.; Anteris Technologies Limited; Abbott Laboratories; Terumo Medical Corporation; Integra LifeSciences Corporation; W. L. Gore & Associates Inc.; Medtronic Inc.; LifeCell Corporation; ACell Inc.; Tissue Regenix Group Plc; Aroa Biosurgery Ltd.; LifeNet Health Inc.; Cook Medical; Getinge AB; Glycar SA Pty Ltd.; Biointegral Surgical Inc.; Admedus Ltd.; Johnson & Johnson; Stryker Corporation; Zimmer Biomet; Smith & Nephew plc; Organogenesis Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Cardiovascular and Soft Tissue Repair Patches market report include:- B. Braun
- Baxter International Inc.
- CorMatrix Cardiovascular Inc.
- CryoLife Inc.
- Edwards Lifesciences Corporation
- LeMaitre Vascular Inc.
- Anteris Technologies Limited
- Abbott Laboratories
- Terumo Medical Corporation
- Integra LifeSciences Corporation
- W. L. Gore & Associates Inc.
- Medtronic Inc.
- LifeCell Corporation
- ACell Inc.
- Tissue Regenix Group Plc
- Aroa Biosurgery Ltd.
- LifeNet Health Inc.
- Cook Medical
- Getinge AB
- Glycar SA Pty Ltd.
- Biointegral Surgical Inc.
- Admedus Ltd.
- Johnson & Johnson
- Stryker Corporation
- Zimmer Biomet
- Smith & Nephew plc
- Organogenesis Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.41 Billion |
| Forecasted Market Value ( USD | $ 8.09 Billion |
| Compound Annual Growth Rate | 10.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 28 |
